Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children’s Oncology Group phase 1 consortium study (ADVL1212)

Emily Greengard, Yaël P. Mossé, Xiaowei Liu, Charles G. Minard, Joel M. Reid, Stephan D. Voss, Keith D. Wilner, Elizabeth Fox, Frank M. Balis, Susan M. Blaney, Peter C. Adamson, Brenda J. Weigel